2019
DOI: 10.1007/s10815-019-01576-w
|View full text |Cite
|
Sign up to set email alerts
|

Embryo transfer strategy and therapeutic options in infertile patients with thin endometrium: a systematic review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
28
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 41 publications
(30 citation statements)
references
References 77 publications
2
28
0
Order By: Relevance
“…Embryo implantation failure caused by the thin endometrium is a serious challenge for assisted reproductive technology, especially since there is no established effective treatment for this condition. In recent years, long-term administration of estrogen, vaginal sildenafil, low-dose aspirin, pentoxifylline, autologous platelet-rich plasma, intrauterine perfusion of G-CSF, and other treatments have been used to treat thin endometrium; however, providing effective evidence-based interventions continues to pose a significant challenge [8,[35][36][37]. Therefore, alternative treatments are needed for patients with thin endometrium.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Embryo implantation failure caused by the thin endometrium is a serious challenge for assisted reproductive technology, especially since there is no established effective treatment for this condition. In recent years, long-term administration of estrogen, vaginal sildenafil, low-dose aspirin, pentoxifylline, autologous platelet-rich plasma, intrauterine perfusion of G-CSF, and other treatments have been used to treat thin endometrium; however, providing effective evidence-based interventions continues to pose a significant challenge [8,[35][36][37]. Therefore, alternative treatments are needed for patients with thin endometrium.…”
Section: Discussionmentioning
confidence: 99%
“…Several interventions have been explored to improve endometrial thickness, such as luteal estradiol, granulocyte colony-stimulating factor (G-CSF), intrauterine infusion of platelet-rich plasma, and treatments that improve uterine blood flow [8]. Thus far, for patients with a thin endometrium, insufficient specific treatments have been clinically used to increase pregnancy or live birth rates [6].…”
Section: Introductionmentioning
confidence: 99%
“…A previous trial showed that PRP efficiently improved the endometrium proliferation, implantation rate, and clinical pregnancy rate [ 48 ]; however, clinical trial data is limited, with the majority being non-randomized trials [ 49 ]. A systematic review indicates that only a few randomized controlled trials support the use of sildenafil in frozen embryo transfer (ET) for enhancing endometrial growth [ 50 ]. Other treatments, such as vitamin E and l-arginine, were all base on small sample size, thus lack sufficient evidence of efficacy [ 51 ].…”
Section: Discussionmentioning
confidence: 99%
“…Several strategies have been proposed to manage thin endometrium in FET cycles, including modification of E 2 use (149)(150)(151), in-utero administration of granulocyte colony stimulating factor (152), in-utero administration of plateletrich plasma (153), vaginal sildenafil (154), oral pentoxyfiline, oral tocopherol (155), oral aspirin (156) or pelvic floor neuromuscular electrical stimulation (157). However, none of these strategies have been unequivocally proven to be of benefit in patients with thin endometrium (158).…”
Section: Endometrial Thickness and Thin Endometriummentioning
confidence: 99%